Quick answer
What does the V8 Peptides research catalog contain? The store lists lyophilized research peptides, multi-peptide blends and one laboratory supply (bacteriostatic water), sorted on the site into Metabolic, Recovery & Tissue, Growth Factor, Anti-Aging & Longevity and Laboratory Supplies. Each product page gives size, a purity specification of ≥98% by HPLC for the peptides, molecular formula, supplied form, storage conditions and a research-use-only statement, and links to a certificate of analysis where one has been published. Several further compounds are shown as coming soon and are not yet on sale. This guide maps the catalog by category, explains how to read a listing and points to the research article for each compound. All materials are for laboratory research use only.
A catalog is easier to use when its structure is understood. This guide is a map: what is listed, how it is grouped, which fields on a product page matter and where to find deeper background for each compound. It describes only what the site itself states. Sizes and availability can change, so the product page is always the authority. Every compound below is supplied for laboratory research use only and is not for human or animal consumption. A general introduction to the category is in what are research peptides.
How the catalog is organized
The shop groups products into five collections. The groupings are a navigation aid and reflect the way the compounds are commonly studied, not any claim about their effects.
| Collection | Typical contents | Starting point |
|---|---|---|
| Metabolic | Incretin-pathway agonists, amylin-receptor agonist, GHRH analog, a hGH fragment and a mitochondrial-derived peptide | GLP-1 receptor agonists in research |
| Recovery & Tissue | BPC-157 and the BPC-157 + TB-500 blend | BPC-157 vs TB-500 |
| Growth Factor | GHRH analogs, growth hormone secretagogues, an IGF-1 analog and a blend | Secretagogues vs hGH |
| Anti-Aging & Longevity | GHK-Cu, a three-peptide blend, NAD+ | GHK-Cu research overview |
| Laboratory Supplies | Neuropeptide and melanocortin-related peptides, tripeptide blends, KLOW stack and bacteriostatic water | Peptide blends and research stacks |
Metabolic collection
These listings concern receptor-signaling and metabolic-pathway research. The incretin and amylin entries are lipidated or modified peptides with particular handling needs, covered in each compound's article.
| Compound | Size(s) listed | What the listing describes |
|---|---|---|
| Semaglutide | 10 mg | Long-acting GLP-1 receptor agonist; lot COA published online where available |
| Tirzepatide | 30 mg | Dual GIP / GLP-1 receptor agonist |
| Retatrutide | 10 mg, 20 mg | Triple GIP, GLP-1 and glucagon receptor agonist |
| Cagrilintide | 10 mg | Long-acting amylin-receptor agonist |
| Tesamorelin | 10 mg | Stabilized GHRH (1-44) analog |
| AOD-9604 | 5 mg | C-terminal fragment of human growth hormone, hGH (176-191) |
| MOTS-c | 10 mg | Mitochondrial-derived peptide encoded in the 12S rRNA, studied in AMPK-signaling research |
Further reading: semaglutide, tirzepatide, retatrutide, cagrilintide, tesamorelin, AOD-9604 and MOTS-c research overviews.
Recovery and Growth Factor collections
Recovery & Tissue holds BPC-157 (10 mg) and the Wolverine stack, which co-lyophilizes BPC-157 10 mg and TB-500 10 mg in one vial. Growth Factor holds GHRH analogs and ghrelin-receptor agonists:
| Compound | Size(s) listed | What the listing describes |
|---|---|---|
| BPC-157 | 10 mg | Synthetic pentadecapeptide examined in tissue-response research |
| Wolverine Stack | 10 mg / 10 mg | BPC-157 and TB-500 in a single co-lyophilized vial |
| CJC-1295 (No DAC) | 5 mg, 10 mg | Modified GRF (1-29) GHRH analog without the Drug Affinity Complex |
| CJC-1295 (No DAC) + Ipamorelin | 5 mg / 5 mg; 10 mg / 10 mg | 1:1 GHRH analog and selective secretagogue blend |
| Ipamorelin | 10 mg | Selective pentapeptide ghrelin-receptor agonist |
| Hexarelin | 5 mg | Synthetic hexapeptide GHS-R agonist |
| Sermorelin | 5 mg, 10 mg | GHRH (1-29) analog |
| IGF-1 LR3 | 1 mg | Long-arginine-3 analog of IGF-1 |
For orientation: BPC-157 research overview, CJC-1295 + ipamorelin research overview, ipamorelin, hexarelin, sermorelin and IGF-1 LR3.
Anti-Aging and Laboratory Supplies collections
| Compound | Size(s) listed | What the listing describes |
|---|---|---|
| GHK-Cu | 50 mg, 100 mg | Naturally occurring copper tripeptide studied in collagen and matrix research |
| Glow Stack | 70 mg total (50 / 10 / 10) | GHK-Cu, BPC-157 and TB-500 in one formulation |
| NAD+ | 1000 mg | Coenzyme studied in cellular energy metabolism and sirtuin research |
| GHK-Cu + KPV | 60 mg blend | Copper tripeptide with KPV, an α-MSH C-terminal tripeptide |
| KLOW Stack | 80 mg blend | GHK-Cu, KPV, BPC-157 and TB-500 blend |
| KPV | 5 mg, 10 mg | C-terminal tripeptide of α-MSH |
| TB-500 | 10 mg | Synthetic 17-23 fragment of thymosin β4 |
| MT-2 (Melanotan II) | 10 mg | Cyclic melanocortin-receptor agonist |
| PT-141 (Bremelanotide) | 10 mg | Melanocortin MC4-receptor agonist |
| Selank | 10 mg | Synthetic tuftsin analog |
| Semax | 15 mg | Synthetic ACTH(4-10) heptapeptide analog |
| Bacteriostatic Water | 10 ml vial | Sterile water containing 0.9% benzyl alcohol, for multi-entry reconstitution work |
Single peptides or blends
Five listings are multi-peptide formulations: the Wolverine, Glow and KLOW stacks, GHK-Cu + KPV and CJC-1295 (No DAC) + ipamorelin. A blend fixes the ratio between components, which saves preparation steps and removes one source of variation between experiments. It also removes the ability to change one component without the other, and it means that any effect seen is the effect of the mixture. A design that needs to attribute a result to one compound needs single-peptide arms as well, which is why most of the compounds in a blend are also listed on their own. The reasoning is worked through in blend versus separate vials and Glow vs KLOW vs Wolverine. Blends containing a copper peptide have an added feature, a blue cake and solution, discussed in does copper degrade other peptides in a blend.
Coming soon
The site also shows a number of compounds as not yet on sale, each with a notification sign-up: 5-Amino-1MQ, DSIP, Epithalon, GHRP-2, LL-37, Melanotan I, NAD+ + MOTS-c, tesamorelin + ipamorelin, thymosin alpha-1 and VIP. Explanatory articles exist for several of them, for example what is LL-37, what is DSIP and what is Epithalon. The listings can change, so the product page shows the current status.
How to read a product page
Each peptide page carries the same set of fields, which makes catalog items comparable.
| Field | What it tells you | What it does not tell you |
|---|---|---|
| Sizes | Mass per vial in mg, or mass per component for blends | Fill-mass accuracy or net peptide content; the certificate is the place for those, where published |
| Purity | A specification of ≥98% by HPLC | The impurity profile, which needs the chromatogram |
| Molecular formula | Composition of the molecule; blends show the word Blend | Salt form or counterion |
| Sequence / identity | Amino acid sequence, or a note that it is reported on the certificate | Anything about stereochemistry beyond what is written |
| Supplied form | Lyophilized powder | Appearance of an individual vial |
| Storage | Refrigerate at 2–8 °C, −20 °C for long-term, protect from heat, moisture and light | Shelf life after reconstitution |
| Research-use statement | Sold for laboratory research and development purposes only | Nothing about suitability for any other use |
Certificates for lots that have them are in the COA library; how to read a COA and understanding HPLC purity explain the fields. Pages show a published-certificate link only where one exists, and pages without one say that documentation is in progress.
Keeping records across a catalog order
When several compounds arrive together, the most useful habit is a one-line receiving record for each vial: product name, size, lot number, date received, appearance, storage location and whether a certificate has been published for that lot. A short spreadsheet is enough. Recording the same fields for every item makes later troubleshooting far quicker, because an odd result can be checked against the physical history of the vial before the experiment itself is questioned. It also keeps blends and single compounds with overlapping components from being confused on the shelf.
Handling anything from the catalog
All peptide listings are lyophilized powder in sealed clear glass vials with the same storage statement. Lyophilization is explained in what is lyophilization, and its consequences for solid-state stability by Wang (2000). In solution, peptides face hydrolysis, deamidation, oxidation and aggregation (Manning and colleagues, 2010; Hawe and colleagues, 2012), freeze–thaw stress (Bhatnagar and colleagues, 2007) and adsorption to labware (Goebel-Stengel and colleagues, 2011). Chemical synthesis and its by-products are reviewed by Bray (2003). The general rules:
- Bring the sealed vial to room temperature before opening; add diluent slowly; swirl, do not shake.
- Pick bacteriostatic water for a vial that will be entered repeatedly and sterile water for stock aliquoted and frozen at once; see bacteriostatic water explained.
- Concentration is vial mass divided by diluent volume; the reconstitution calculator does the arithmetic and its guide explains the inputs.
- Aliquot once; plan for a single thaw; keep solutions cold and in the dark; see storing research peptides.
The complete listing, with filters, is on the shop page. For choosing between suppliers in general, see choosing a peptide supplier; for what is in a stack and why, best research peptide stacks.
Frequently asked questions
How is the V8 catalog organized?
Into five collections on the site: Metabolic, Recovery & Tissue, Growth Factor, Anti-Aging & Longevity and Laboratory Supplies.
What does every peptide product page include?
Size, a purity specification of ≥98% by HPLC, molecular formula, sequence or a note pointing to the certificate, supplied form, storage conditions, container and a research-use-only statement.
What form do the peptides come in?
Lyophilized powder in a sealed clear glass research vial.
How are the products stored?
The pages state 2–8 °C, with −20 °C for the long term, protected from heat, moisture and light.
Are certificates of analysis available?
Where one has been published for a lot, a link appears on the product page and in the COA library. Pages without one state that documentation is in progress.
Which compounds are listed as coming soon?
At the time of writing: 5-Amino-1MQ, DSIP, Epithalon, GHRP-2, LL-37, Melanotan I, NAD+ + MOTS-c, tesamorelin + ipamorelin, thymosin alpha-1 and VIP. Check each page for current status.
Does the catalog include blends?
Yes: the Wolverine, Glow and KLOW stacks, GHK-Cu + KPV and CJC-1295 (No DAC) + ipamorelin, with component masses or total blend mass stated on each page.
Is there a laboratory supply in the catalog?
Bacteriostatic water, a 10 ml vial of sterile water with 0.9% benzyl alcohol listed for multi-entry reconstitution work.
How is reconstitution concentration worked out?
Vial mass divided by diluent volume. The reconstitution calculator performs the arithmetic and records the inputs.
Are these products for use in people or animals?
No. Everything in the catalog is sold strictly for laboratory research and development purposes and is not for human or animal consumption.
Related reading: Why Researchers Study Multi-Peptide Systems, Peptide Facts Every Researcher Should Know.
Related reading: Longevity Research Peptides: Pathways and Laboratory Models.
References
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. doi:10.1016/S0378-5173(00)00423-3
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
- Hawe A, Wiggenhorn M, van de Weert M, Garbe JHO, Mahler HC, Jiskoot W. Forced degradation of therapeutic proteins. J Pharm Sci. 2012;101(3):895-913. doi:10.1002/jps.22812
- Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol. 2007;12(5):505-523. doi:10.1080/10837450701481157
- Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
- Bray BL. Large-scale manufacture of peptide therapeutics by chemical synthesis. Nat Rev Drug Discov. 2003;2(7):587-593. doi:10.1038/nrd1133
- Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem. 1987;262(2):785-794. doi:10.1016/S0021-9258(19)75855-4
- Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-188. doi:10.1016/S0378-5173(99)00152-0
